Metformin May Reduce Prostate Cancer Risk, New Meta-Analysis Finds
Recent studies suggest that metformin, a diabetes medication, may reduce the risk of prostate cancer. A meta-analysis found that metformin users had a lower incidence of prostate cancer. While metformin did not significantly impact cancer recurrence or mortality rates, its effectiveness varied based on study type and geographic population. The duration of metformin use also played a role in its protective effects against prostate cancer.
Study Shows Metformin May Reduce Risk of Blood Cancer
A recent study reveals that the diabetes drug metformin may reduce the risk of blood cancer, specifically myeloproliferative neoplasm (MPN). Apart from its primary function, metformin has shown potential in lowering the risk of colorectal, breast, and prostate cancers, as well as cancer-related death. The drug’s benefits also include anti-aging effects, weight loss, improved fertility in individuals with PCOS, and potential cardiovascular health enhancements.
Metformin Shows Promise in Reducing SARS-CoV-2 Levels in Clinical Trial
A recent clinical trial by University of Minnesota researchers found that the common diabetes drug metformin can reduce SARS-CoV-2 levels in the body, potentially lowering the risk of rebound symptoms. The study focused on standard-risk individuals and showed that metformin could decrease viral load, prevent hospitalization or death, and reduce the incidence of long COVID. Early intervention with metformin led to a 3.6-fold reduction in viral load by day 10 and decreased the likelihood of hospitalization or death by 58% within 28 days.
Study Suggests Diabetes Drug Metformin May Have Anti-Aging Effects
Recent study suggests that metformin, a common diabetes drug, may have anti-inflammatory effects that could protect against age-related diseases. The TAME Trial is investigating metformin’s role in promoting healthier aging. Individuals like Michael and Shari Cantor have reported feeling energetic and healthy on metformin, which is affordable and may have potential to extend lifespan.
Aging as a Treatable Condition: Dr. Nir Barzilai’s Approach
Dr. Nir Barzilai advocates for a holistic approach to aging, aiming to slow down or even reverse the aging process using readily available and affordable drugs. He focuses on targeting the underlying mechanisms of aging itself, addressing the 12 identified ‘hallmarks of aging.’ His work reflects a shift in the approach to aging, moving beyond managing individual health conditions to targeting aging itself as a treatable condition.